Benchmark Upgrades Regeneron Pharma (REGN) to Buy

January 13, 2021 4:51 AM

Benchmark analyst Aydin Huseynov upgraded Regeneron Pharma (NASDAQ: REGN) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found